Paratek Pharmaceuticals (PRTK) Announces FDA Approval for SEYSARA to Treat Moderate to Severe Acne
Tweet Send to a Friend
Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) announced that the U.S. Food and Drug Administration (FDA) has approved SEYSARA™ (sarecycline) for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
